24 Chapter 55. Cortés RM, Pastor JFS, Dolz VM. Chronic pain in adults with osteogenesis imperfecta and its relationship to appraisal, coping, and quality of life: A cross-sectional study. Medicine (United States) 2022; 101. DOI:10.1097/MD.0000000000030256. 56. Campbell RD, Bagshaw M. Human Performance and Limitations in Aviation. 2002 DOI:10.1002/9780470774472. 57. Giallo R, Gartland D, Woolhouse H, Brown S. “I didn’t know it was possible to feel that tired”: exploring the complex bidirectional associations between maternal depressive symptoms and fatigue in a prospective pregnancy cohort study. Arch Womens Ment Health 2016; 19. DOI:10.1007/s00737-014-0494-8. 58. Dogba MJ, Bedos C, Durigova M, et al. The impact of severe osteogenesis imperfecta on the lives of young patients and their parents - a qualitative analysis. BMC Pediatr 2013; 13. DOI:10.1186/1471-2431-13-153. 59. Boender J, Kruip MJHA, Leebeek FWG. A diagnostic approach to mild bleeding disorders. Journal of Thrombosis and Haemostasis 2016; 14: 1507–16. 60. Sadler JE. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem 1998; 67. DOI:10.1146/annurev.biochem.67.1.395. 61. Malfait F, Paepe A De. Bleeding in the heritable connective tissue disorders: Mechanisms, diagnosis and treatment. Blood Rev 2009; 23. DOI:10.1016/j.blre.2009.06.001. 62. Kirtava A, Crudder S, Dilley A, Lally C, Evatt B. Trends in clinical management of women with von Willebrand disease: A survey of 75 women enrolled in Haemophilia Treatment Centres in the United States. Haemophilia 2004; 10. DOI:10.1046/j.1351-8216.2003.00832.x. 63. Moenen FCJI, Nelemans PJ, Schols SEM, Schouten HC, Henskens YMC, Beckers EAM. The diagnostic accuracy of bleeding assessment tools for the identification of patients with mild bleeding disorders: A systematic review. Haemophilia. 2018; 24. DOI:10.1111/hae.13486. 64. Mayer SA, Rubin BS, Starman BJ, Byers PH. Spontaneous multivessel cervical artery dissection in a patient with a substitution of alanine for glycine (G13A) in the α1(I) chain of type I collagen. Neurology 1996; 47: 552–6. 65. Edge G, Okafor B, Fennelly ME, Ransford AO. An unusual manifestation of bleeding diathesis in a patient with osteogenesis imperfecta. Eur J Anaesthesiol 1997; 14: 215–9. 66. Kastrup M, von Heymann C, Hotz H, et al. Recombinant factor VIIa after aortic valve replacement in a patient with osteogenesis imperfecta. Ann Thorac Surg 2002; 74: 910–2. 67. Mondal RK, Mann U, Sharma M, Mondal RK, Mann U, Sharma M. Osteogenesis imperfecta with bleeding diathesis. Indian J Pediatr 2003; 70: 95–6. 68. Faqeih E, Roughley P, Glorieux FH, Rauch F. Osteogenesis imperfecta type III with intracranial hemorrhage and brachydactyly associated with mutations in exon 49 of COL1A2. Am J Med Genet A 2009; 149A: 461–5.
RkJQdWJsaXNoZXIy MTk4NDMw